Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma

被引：0
作者：
Chun-Teng Huang
Chia-Jen Liu
Po-Shen Ko
Han-Tsung Liu
Yuan-Bin Yu
Liang-Tsai Hsiao
Jyh-Pyng Gau
Cheng-Hwai Tzeng
Tzeon-Jye Chiou
Jin-Hwang Liu
Muh-Hwa Yang
Ling-Ju Huang
Chun-Yu Liu
机构：
[1] Taipei Veterans General Hospital,Division of Hematology & Oncology, Department of Medicine
[2] National Yang-Ming University School of Medicine,Division of Transfusion Medicine, Department of Medicine
[3] Taipei Veterans General Hospital,Division of Hematology & Oncology, Department of Medicine
[4] Yang-Ming Branch of Taipei City Hospital,Division of General Medicine, Department of Medicine
[5] Taipei Veterans General Hospital,Division of Medical Oncology, Department of Oncology
[6] Taipei Veterans General Hospital,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Bloodstream infection; Multiple myeloma; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review
    Hira Mian
    M. Brouwers
    C. T. Kouroukis
    T. M. Wildes
    The Journal of Frailty & Aging, 2019, 8 : 215 - 221
  • [42] Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments
    Zhang, Yanjie
    Pan, Juan
    Kang, Haixin
    Peng, Shuotao
    Tung, Tao-Hsin
    Shen, Bo
    ANNALS OF HEMATOLOGY, 2023, 102 (04) : 801 - 809
  • [43] COMPARISON OF FRAILTY SCORES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA: A REVIEW
    Mian, H.
    Brouwers, M.
    Kouroukis, C. T.
    Wildes, T. M.
    JOURNAL OF FRAILTY & AGING, 2019, 8 (04) : 215 - 221
  • [44] Modern treatments and future directions for newly diagnosed multiple myeloma patients
    Lu, Sydney X.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (01)
  • [45] Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma
    Jena, Rabindra Kumar
    Swain, Trupti Rekha
    Kansurkar, Sandeep Sadashivrao
    Swain, Manorama
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 881 - 884
  • [46] Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma
    Wang, Chaoyu
    Wu, Ling
    Sun, Chengtao
    Zhang, Yizhuo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (02): : 619 - 627
  • [47] Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments
    Yanjie Zhang
    Juan Pan
    Haixin Kang
    Shuotao Peng
    Tao-Hsin Tung
    Bo Shen
    Annals of Hematology, 2023, 102 : 801 - 809
  • [48] Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma
    Rabindra Kumar Jena
    Trupti Rekha Swain
    Sandeep Sadashivrao Kansurkar
    Manorama Swain
    European Journal of Clinical Pharmacology, 2012, 68 : 881 - 884
  • [49] Clinical treatment of newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 595 - 611
  • [50] Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma
    Bici, Anisa
    Pianko, Matthew J.
    Nachar, Victoria R.
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 407 - 414
12345